The majority of the available data show that the cholestatic pattern of injury is less common in COVID-19 patients than AST and ALT, but mildly raised GGT levels can be seen in up to 50% of patients [7,21,22,23,24,35,38,39,40]. The gene discussed is GPT; the disease is COVID-19.